Antisense blockade of p21/WAF1 decreases radiation-induced G2 arrest in esophageal squamous cell carcinoma

Journal of Surgical Research

Volumn 81, Issue 1, 1999, Pages 6-10

  Rigberg, David A ^a   Blinman, Thane A ^a   Kim, Frances S ^a   Cole, Michael A ^a   McFadden, David W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell cycle; Esophageal cancer; p21; Squamous cell

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; PROTEIN P21;

ARTICLE; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL CYCLE G2 PHASE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOBIOLOGY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

EID: 0032854740     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5483     Document Type: Article

References (26)

1. Swisher S. G., Hunt K. K., Holmes E. C., Zinner M. J., McFadden D. W. Changes in the surgical management of esophageal cancer from 1970 to 993. Am. J. Surg. 169:1995;609.
2. Berrino F., Sant M., Verdecchia A., Capacaccia R., Hakulinen T., Esteve J. Survival of Cancer Patients in Europe - The Eurocare Study. 1995;IARC, Lyon.
3. Stein H. Esophageal cancer: Screening and surveillance. Dis. Esoph. 9:1996;3.
4. Blot W. J., Devesa S. S., Kneller R. W., Fraumeni J. F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 265:1991;1287.
5. Altorki N. K., Skinner D. B. Adenocarcinoma in Barrett's esophagus. Semin. Surg. Oncol. 6:1990;274.
6. Kelsen D., Atiq O. T. Therapy of upper gastrointestinal tract cancers. Curr. Prob. Cancer. 15:1991;235.
7. Bhansali M. S., Patil P. K., Badwe R. A., Havaldar R., Desai P. B. Historical control bias; adjuvant chemotherapy in esophageal cancer. Dis. Esoph. 10:1997;51.
8. Wadler S., Hayner H., Beitler J. J., Hu X., Fell S., Camacho M., Levine B., Wiernik P. H. Phase II clinical trial with 5-FU, recombinant interferon-alpha-2b and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus. Cancer. 78:1996;30.
9. Tanaka H., Shibagak I., Shimada Y., Wagata T., Imamura M., Ishizaki K. Characterization of p53 gene mutations in esophageal squamous cell carcinoma cell lines: Increased frequency and different spectrum of mutations from primary tumors. Int. J. Cancer. 65:1996;372.
10. El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF-1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817.
11. Macleod K. F., Sherry N., Hannon G., Beach D., Tokino T., Kinzler K., Vogelstein B., Jacks T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9:1995;935.
12. El-Deiry W. S., Harper J. W., O'Conner P. M., Velculescu V. E., Canman C. E., Jackman J., Pietenpol J. A., Burrell M., Hill D. E., Wang Y., Wiman K. G., Mercer W. E., Kastan M. B., Kohn K. W., Elledge S. J., Kinzler K. W., Vogelstein B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1994;1169.
13. Wang J., Walsh K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science. 273:1996;359.
14. Harper J. W., Elledge S. J., Keyomarsi K., Dynlacht B., Tsai L. H., Zhang P., Dobrowlski C., Bai, Connell C. L., Swindell E., Fox M. P., Wei N. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6:1995;287.
15. Li Y., Jenkins C. W., Nichols M. A., Xiong Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene. 9:1994;2261.
16. Dulic V., Stein G. H., Far D. F., Reed S. I. Nuclear accumulation of p21/Cip1 at the onset of mitosis: A role at the G2/M-phase transition. Mol. Cell. Biol. 18:1998;546.
17. Niculescu A. B. III, Chen X., Smeets M., Hengst L., Prives C., Reed S. I. Effects of p21/Cip1/Waf1 at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18:1998;629.
18. Rigberg, D. A. Kim, F. S. Blinman, T. A. Cole, M. A. Lane, J. S. So, J. McFadden, D. W. p21 expression is increased by irradiation in esophageal squamous cell carcinoma, J. Surg. Res.
19. Nevins J. R. E2F: A link between the Rb tumor suppressor protein and viral oncoproteins. Science. 258:1994;424.
20. Sherr C. J., Roberts J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149.
21. Beamish H., Williams R., Chen P., Lavin M. F. Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J. Biol. Chem. 271:1996;20486.
22. Guadagno T. M., Newport J. W. Cdk2 kinase is required for entry into mitosis as a positive regulator of cdc2-cyclin B kinase activity. Cell. 67:1991;1169.
23. Tchou W. W., Rom W. N., Wong K. M. T. Novel form of p21/WAF1/Cip1/SDI1 protein in phorbol ester-induced G2/M arrest. J. Biol. Chem. 271:1996;29556.
24. Shimizu A., Nishida J., Ueoka Y., Kato K., Hachiya T., Kuriaki Y., Wake N. Cyclin G contributes to G2/M arrest of cells in response to DNA damage. Biochem. Biophys. Res. Commun. 242:1998;529.
25. Arita D., Kambe M., Ishioka C., Kanamaru R. Induction of p53-independent apoptosis associated with G2M arrest following DNA damage in human colon cancer cell lines. Jpn. J. Cancer Res. 88:1997;39.
26. Lydall D., Weinert T. Yeast checkpoint genes in DNA damage processing: Implications for repair and arrest. Science. 270:1995;1488.